Ultragenyx

Lack of early win for Ultragenyx’s bone disorder med dents stock

Analysts are keeping faith in Ultragenyx’s brittle bone disease medicine despite the monoclonal antibody failing to score an early outright trial win.

James Waldron Jul 10, 2025 8:04am

An illustration of a white strand of DNA which lies horizontally across an image

Ultragenyx tweaks gene therapy dosing to dial up efficacy

Oct 4, 2024 8:46am

Ultragenyx gets green light to seek FDA approval of gene therapy

Jun 13, 2024 5:55am

broken bone fracture break x ray skeleton

Ultragenyx, Mereo's brittle bone drug sustains fracture rate cut

Jun 12, 2024 8:55am

Ultragenyx's ph. 3 win for glycogen storage disease gene therapy

May 30, 2024 4:00pm

Ultragenyx, Mereo's bone disease med cuts fractures by 67%

Oct 16, 2023 12:39pm